ICYMI: FDA Approves the Fourth Deep Brain Stimulator System for Parkinson’s With BrainSense Technology
source: pixabay.com

ICYMI: FDA Approves the Fourth Deep Brain Stimulator System for Parkinson’s With BrainSense Technology

  Medtronic’s Percept is the fourth deep brain stimulation (DBS) system that has been approved by the FDA according to a recent article in Parkinson’s News Today. The unique feature…

Continue Reading ICYMI: FDA Approves the Fourth Deep Brain Stimulator System for Parkinson’s With BrainSense Technology
Parkinson’s Disease: BEAT-PD Dream Contest Winners Announced
https://pixabay.com/en/balloons-party-colors-rubber-fly-1786430/

Parkinson’s Disease: BEAT-PD Dream Contest Winners Announced

  Launched in January of 2020, and ending in May, the BEAT-PD Dream Challenge was designed to understand whether passive data collected from sensors could track symptom severity and disease progression…

Continue Reading Parkinson’s Disease: BEAT-PD Dream Contest Winners Announced
Biomarkers in Alzheimer’s Give Researchers a Heads Up to Predict Early Parkinson’s Disease
source: pixabay.com

Biomarkers in Alzheimer’s Give Researchers a Heads Up to Predict Early Parkinson’s Disease

  Parkinson’s News Today recently published an article containing new information about biomarkers in Alzheimer’s disease that can be linked to the early stages of Parkinson’s disease. Many people with…

Continue Reading Biomarkers in Alzheimer’s Give Researchers a Heads Up to Predict Early Parkinson’s Disease

Researchers Find that Disturbances in the Body’s Internal Clock Increase the Risk of Parkinson’s Disease Threefold

According to a recent article in Parkinson’s News Today, researchers at the UCSF Weill Institute discovered that disturbances in circadian rhythm increased a person’s risk of Parkinson's disease threefold. Circadian…

Continue Reading Researchers Find that Disturbances in the Body’s Internal Clock Increase the Risk of Parkinson’s Disease Threefold
Study: Nuplazid Demonstrates its Impact in Parkinson’s Disease Patients
source: pixabay.com

Study: Nuplazid Demonstrates its Impact in Parkinson’s Disease Patients

  According to a recent article in Parkinson’s News Today, results of an extension study confirm that FDA approved Nuplazid (pimavanserin) reduces the severity of delusions and hallucinations in Parkinson’s disease…

Continue Reading Study: Nuplazid Demonstrates its Impact in Parkinson’s Disease Patients

A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients

Parkinson's News Today recently published an article featuring a study in Italy showing the benefits of deep brain stimulation in patients with late-stage Parkinson’s disease. The history of the subthalamic…

Continue Reading A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients
$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders
QuinceMedia / Pixabay

$950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders

Every day, the world becomes increasingly technological. With this comes advances in many realms, from healthcare to education. Recently, says Parkinson's News, medical technology company Manus Neurodynamica received £750,000 (approx. $950,000)…

Continue Reading $950,000 Raised to Fund NeuroMotor Pen, A Diagnostic Tool for Neurological Disorders